Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer
Authors
Keywords
-
Journal
Nature Communications
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-05-01
DOI
10.1038/s41467-020-16079-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Deep phenotyping of immune cell populations by optimized and standardized flow cytometry analyses
- (2018) Fabien Pitoiset et al. CYTOMETRY PART A
- Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
- (2017) V. Gopalakrishnan et al. SCIENCE
- Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients
- (2017) Arthur E. Frankel et al. NEOPLASIA
- Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis
- (2016) Krista Dubin et al. Nature Communications
- Rational Selection of Syngeneic Preclinical Tumor Models for Immunotherapeutic Drug Discovery
- (2016) Suzanne I.S. Mosely et al. Cancer Immunology Research
- Ipilimumab reshapes T cell memory subsets in melanoma patients with clinical response
- (2016) Joana Felix et al. OncoImmunology
- Erratum: Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25
- (2015) Dalil Hannani et al. CELL RESEARCH
- Short-chain fatty acids in control of body weight and insulin sensitivity
- (2015) Emanuel E. Canfora et al. Nature Reviews Endocrinology
- Pembrolizumab versus Ipilimumab in Advanced Melanoma
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
- (2015) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy
- (2015) A. Sivan et al. SCIENCE
- Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
- (2015) M. Vetizou et al. SCIENCE
- Diet, Metabolites, and “Western-Lifestyle” Inflammatory Diseases
- (2014) Alison N. Thorburn et al. IMMUNITY
- Mucosa-associated Faecalibacterium prausnitzii and Escherichia coli co-abundance can distinguish Irritable Bowel Syndrome and Inflammatory Bowel Disease phenotypes
- (2014) Mireia Lopez-Siles et al. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
- Phylogenetic distribution of three pathways for propionate production within the human gut microbiota
- (2014) Nicole Reichardt et al. ISME Journal
- Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells
- (2013) Yukihiro Furusawa et al. NATURE
- Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
- (2013) Nicholas Arpaia et al. NATURE
- The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic Treg Cell Homeostasis
- (2013) P. M. Smith et al. SCIENCE
- Butyrate interferes with the differentiation and function of human monocyte-derived dendritic cells
- (2012) Lu Liu et al. CELLULAR IMMUNOLOGY
- Microbial Regulation of Glucose Metabolism and Cell-Cycle Progression in Mammalian Colonocytes
- (2012) Dallas R. Donohoe et al. PLoS One
- Application of quantitative real-time PCR for rapid identification of Bacteroides fragilis group and related organisms in human wound samples
- (2011) Jia Tong et al. ANAEROBE
- The ICOS/ICOSL Pathway Is Required for Optimal Antitumor Responses Mediated by Anti-CTLA-4 Therapy
- (2011) T. Fu et al. CANCER RESEARCH
- The Microbiome and Butyrate Regulate Energy Metabolism and Autophagy in the Mammalian Colon
- (2011) Dallas R. Donohoe et al. Cell Metabolism
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
- (2011) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trans-Endocytosis of CD80 and CD86: A Molecular Basis for the Cell-Extrinsic Function of CTLA-4
- (2011) O. S. Qureshi et al. SCIENCE
- Butyrate and other short-chain fatty acids as modulators of immunity: what relevance for health?
- (2010) Kees Meijer et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Diet, gut microbiota and immune responses
- (2010) Kendle M Maslowski et al. NATURE IMMUNOLOGY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Short chain fatty acids exchange across the gut and liver in humans measured at surgery
- (2009) Johanne G. Bloemen et al. CLINICAL NUTRITION
- Diversity of human colonic butyrate-producing bacteria revealed by analysis of the butyryl-CoA:acetate CoA-transferase gene
- (2009) Petra Louis et al. ENVIRONMENTAL MICROBIOLOGY
- Comparative assessment of human and farm animal faecal microbiota using real-time quantitative PCR
- (2009) Jean-Pierre Furet et al. FEMS MICROBIOLOGY ECOLOGY
- CD28 and CTLA-4 coreceptor expression and signal transduction
- (2009) Christopher E. Rudd et al. IMMUNOLOGICAL REVIEWS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now